Sign in
Active, not recruitingNo phase

VT ART Consortium: Radioablation for Ventricular Tachycardia

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
52 people, planned
Started
26 Nov 2024
Expected to end
31 Oct 2029
Type of study
Interventional
Treatments tested
  • Stereotactic Body Radiation Therapy (SBRT)
Record updated
11 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Patients with refractory VT
  • age > 18 years
  • Patients with ICDs for follow-up
  • Ineligible for heart transplantation
  • Prognosis of not less than 1 year
  • Ability to express autonomous consent to therapies or (in case of inability due to clinical condition) deferred consent (first indicated by the referring clinician, later expressed by the patient once recovered to autonomous condition

Who cannot take part

  • Patients with active neoplastic disease undergoing oncological treatment
  • Evaluation of ICD demonstrating polymorphic VT
  • Patients with INTERMACS class greater than 4
  • Patients with LVAD

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The overall objective of the study is to evaluate the efficacy and safety of stereotactic radiation therapy in the non invasive ablation of ventricular tachycardia refractory to any other type treatment.

The group in the trial

  • Refractory ventricular tachycardia patientsTreatment being tested

    Patients with refractory VT as defined above 1. age \> 18 years 2. ICD patients for follow-up 3. Not eligible for heart transplantation. 4. Prognosis not less than 1 year. They will have an initial assessment to verify that condition met the inclusion criteria required for participation, such as.It will be performed * 12-lead ECG * Echocardiography * CT scan of the chest * Laboratory analysis: NT proBNP, HS Troponin I * PMK device evaluation and clinical ECG storage. They will undergo stereotactic treatment on the arrhythmogenic cardiac site

    Treatment: Stereotactic Body Radiation Therapy (SBRT)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
VT-ART-P: Ventricular Tachycardia Ablation and RadioTherapy, a Prospective Study
Record updated
11 May 2025